Silver Book Fact

A meta-analysis of antidepressants found that 1 in 3 patients with persistent neuropathic pain will get at least moderate pain relief. Another meta-analysis of duloxetine found it useful for treating persistent pain from fibromyalgia and diabetic neuropathy.

Saarto T, Wiffen P. Antidepressants for Neuropathic Pain. Cochrane Database of Systematic Reviews. 2007; http://summaries.cochrane.org/CD005454/antidepressants-for-treating-neuropathic-pain

Reference

Title
Antidepressants for Neuropathic Pain
Publication
Cochrane Database of Systematic Reviews
Publication Date
2007
Authors
Saarto T, Wiffen P
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Advances in neuroimaging will continue to offer information on the brain’s functioning and how it correlates to the pain experience.  
  • Pregalbin, an antiepileptic drug, produced around a 32% pain reduction (a significant reduction) at week 16 versus around 20% for placebo, in patients with neuropathic pain due to spinal cord…  
  • Researchers have developed several sub-types of ion channels that allow inflammation and growth factors to trigger persistent pain.  
  • A meta-analysis of duloxetine, an anti-depressant, found a 50% reduction in pain at 12 weeks for diabetic peripheral neuropathy, and a 50% reduction in pain at 12 weeks for fibromyalgia.  
  • Targeting A-type K+ channels in primary sensory neurons could provide a novel mechanism-based therapy for the treatment of bone cancer pain–one of the most severe types of chronic pain.